Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX Current ratio

Current ratio at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
4.1×-5.6×
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
2×-0.4×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
3.1×+0.5×
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
7.6×-0.7×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
1.5×-3.0×
PVL
Palvella TherapeuticsPVLA
28.9×+20.0×

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—

Where this comes from

Calculated from BioCryst Pharmaceuticals’s reported figures.

total current assets/total current liabilities=1.9×

Based on the most recent quarter.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's current ratio?
BioCryst Pharmaceuticals (BCRX) reported current ratio of 1.9× in Q1 2026.
How has BioCryst Pharmaceuticals's current ratio changed year-over-year?
BioCryst Pharmaceuticals's current ratio decreased by 34.8% year-over-year, from 2.9× to 1.9×.
What is the long-term trend for BioCryst Pharmaceuticals's current ratio?
Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's current ratio has grown at a -7.6% compound annual growth rate (CAGR), from 3.1× to 2.1×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.